Cargando…

Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: Results of a Multicentre Prospective Study

Objectives: Data on clinical and biological tolerance of tedizolid (TZD) prolonged therapy are lacking. Methods: We conducted a prospective multicentre study including patients with prosthetic joint infections (PJIs) who were treated for at least 6 weeks but not more than 12 weeks. Results: Thirty-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senneville, Eric, Dinh, Aurélien, Ferry, Tristan, Beltrand, Eric, Blondiaux, Nicolas, Robineau, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824147/ https://www.ncbi.nlm.nih.gov/pubmed/33374817 http://dx.doi.org/10.3390/antibiotics10010004

Ejemplares similares

315. Oral Vs. Intravenous Antibiotic Treatment for Gram-Positive Prosthetic Joint Infections: A Retrospective Study
por: Coehlo, Alexandre, et al.
Publicado: (2018)

Daptomycin versus Vancomycin as Post-Operative Empirical Antibiotic Treatment for Prosthetic Joint Infections: A Case-Control Study
por: Joseph, C, et al.
Publicado: (2019)

Surgical techniques for Bone Biopsy in Diabetic Foot Infection, and association between results and treatment duration
por: Senneville, Eric, et al.
Publicado: (2020)

Do Anti-Biofilm Antibiotics Have a Place in the Treatment of Diabetic Foot Osteomyelitis?
por: Senneville, Eric, et al.
Publicado: (2023)

Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study
por: Ferry, Tristan, et al.
Publicado: (2021)

Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations
por: Fiaux, E., et al.
Publicado: (2016)

Safety and tolerability of tedizolid as oral treatment for bone and joint infections
por: Miller, Loren G., et al.
Publicado: (2023)

306. Safety and Tolerability of Tedizolid as Oral Treatment for Bone and Joint Infections
por: Launer, Bryn, et al.
Publicado: (2018)

Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Staphylococcus epidermidis Prosthetic-Joint Infection
por: Ferry, Tristan, et al.
Publicado: (2018)

299. Tolerance and Serum Concentration of Cefepime Used Subcutaneously (SC) in the Management of Bone and Joint Infections
por: Assaf, Addy, et al.
Publicado: (2018)

700 A cohort of pneumococcal bone and joint infections in adult patients
por: Mahieu, Rafael, et al.
Publicado: (2014)

Erysipelas or cellulitis with a prosthetic joint in situ
por: Wouthuyzen-Bakker, Marjan, et al.
Publicado: (2018)

In vitro activity of tedizolid and linezolid against Staphylococcus epidermidis isolated from prosthetic joint infections
por: Littorin, C., et al.
Publicado: (2017)

2421. Tedizolid Is Well-Tolerated Among Patients Receiving Prolonged Treatment Courses
por: Marini, Rachel V, et al.
Publicado: (2018)

Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus
por: Senneville, Eric, et al.
Publicado: (2011)

Tolerability of High Doses of Daptomycin in the Treatment of Prosthetic Vascular Graft Infection: A Retrospective Study
por: Legout, Laurence, et al.
Publicado: (2014)

2141. Characteristics and Prognosis of Patients with a Prosthetic Vascular Graft Infection (PVGI): A Prospective Cohort of 200 patients
por: Pasquet, Armelle, et al.
Publicado: (2018)

Ceftobiprole: a potential empirical post-operative monotherapy in prosthetic joint infections
por: Duployez, Claire, et al.
Publicado: (2020)

A rare case of invasive non-typeable Haemophilus influenzae spondylodiscitis and periprosthetic joint infection
por: Sermet, Kevin, et al.
Publicado: (2021)

Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection
por: Shaw, Timothy David, et al.
Publicado: (2021)

1289. Assessing the Safety and Efficacy with Prolonged Use of Tedizolid in Orthopedic Patients
por: Garza, Daniel E, et al.
Publicado: (2023)

Coxiella burnetti prosthetic joint infection in an immunocompromised woman: iterative surgeries, prolonged ofloxacin-rifampin treatment and complex reconstruction were needed for the cure
por: Miailhes, Patrick, et al.
Publicado: (2021)

Impact on the Gut Microbiota of Intensive and Prolonged Antimicrobial Therapy in Patients With Bone and Joint Infection
por: Levast, Benoît, et al.
Publicado: (2021)

2579. Impact on the Gut Microbiota of the Prolonged Antimicrobial Therapy in Patients with Bone and Joint Infection (BJI): Results From the OSIRIS Prospective Study in France
por: Levast, Benoit, et al.
Publicado: (2019)

1627. Tedizolid is Well-tolerated Among Patients Receiving Prolonged Treatment Courses, Including Those Who are Intolerant of Alternative Agents
por: Smith, Brandon, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

Arthroscopic “Debridement and Implant Retention” With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection
por: Ferry, Tristan, et al.
Publicado: (2021)

Computerized registry as a potential tool for surveillance and management of complex bone and joint infections in France: French registry of complex bone and joint infections
por: Lemaignen, Adrien, et al.
Publicado: (2020)

Mycobacterium mucogenicum bacteremia: major role of clinical microbiologists
por: Pradier, Maxime, et al.
Publicado: (2018)

Bilateral One-Stage Revision of Infected Total Hip Arthroplasties: Report of Two Cases and Management of Antibiotic Therapy
por: Pommepuy, Thomas, et al.
Publicado: (2016)

A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention
por: Morata, Laura, et al.
Publicado: (2014)

Hematogenous osteomyelitis in childhood can relapse many years later into adulthood: A retrospective multicentric cohort study in France
por: Clerc, Axelle, et al.
Publicado: (2020)

In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid
por: Zhang, Huiyun, et al.
Publicado: (2022)

Periprosthetic Joint Infections: Clinical and Bench Research
por: Legout, Laurence, et al.
Publicado: (2013)

2287. Real-world Use of Tedizolid Phosphate: A Case Series of Long-Term Tolerability
por: Morrisette, Taylor, et al.
Publicado: (2019)

A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen
por: Karaushi, Haruka, et al.
Publicado: (2022)

Tedizolid Phosphate: a Next-Generation Oxazolidinone
por: Rybak, Jeffrey M., et al.
Publicado: (2015)

Tedizolid: new data and experiences for clinical practice
por: Lletí, Miguel Salavert, et al.
Publicado: (2021)

Familial Transmission of emm12 Group A Streptococcus
por: Duployez, Claire, et al.
Publicado: (2017)

Case Studies and Literature Review of Francisella tularensis–Related Prosthetic Joint Infection
por: Ponderand, Léa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m0a0c5l8tvhhh9khokn73bs3ub